TVTX FY 2018 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$164M+6.0% YoY

Gross Profit

$159M96.6% margin

Operating Income

-$80M-48.7% margin

Net Income

-$103M-62.5% margin

EPS (Diluted)

$-2.54

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$45M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$709M

Total Liabilities

$391M

Stockholders' Equity

$318M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$164M	$155M	+6.0%
Gross Profit	$159M	$151M	+4.9%
Operating Income	-$80M	-$54M	-48.8%
Net Income	-$103M	-$60M	-71.9%